Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Cell Cycle (Georgetown, Tex.)|May 27, 2005
MDM2 as a critical effector of the MYCN oncogene in tumorigenesisAndrew Slack, Jason M ShohetAnnual Review of Medicine|November 12, 2014
Neuroblastoma: molecular pathogenesis and therapyChrystal U Louis, Jason M ShohetCancer Letters|June 2, 2005
MDM2 as MYCN transcriptional target: implications for neuroblastoma pathogenesisAndrew Slack, Guillermina Lozano, Jason M ShohetBiomedicines|January 23, 2024
A Novel Druggable Dual-Specificity tYrosine-Regulated Kinase3/Calmodulin Kinase-like Vesicle-Associated Signaling Module with Therapeutic Implications in NeuroblastomaEsteban J Rozen, Kim Wigglesworth, Jason M ShohetCell and Tissue Research|December 10, 2017
Neuroblastoma pathogenesis: deregulation of embryonic neural crest developmentJulie A Tomolonis, Saurabh Agarwal, Jason M ShohetCurrent Protocols in Pharmacology|September 22, 2011
Preclinical models of pediatric solid tumors (neuroblastoma) and their use in drug discoveryDanielle M Patterson, Jason M Shohet, Eugene S KimJournal of Cellular Biochemistry|July 19, 2016
CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker FamilyPeter E Zage, Sarah B Whittle, Jason M ShohetBio-Protocol|August 20, 2016
In vivo Lineage-tracing Studies in a Cancer Stem Cell Population in NeuroblastomaDanielle M Hsu, Jason M Shohet, Eugene S KimWorld Journal of Surgery|February 12, 2005
Gene profiling of high risk neuroblastomaSanjeev A Vasudevan, Jed G Nuchtern, Jason M ShohetAnticancer Research|July 1, 2015
CD114 Expression Mediates Melanoma Tumor Cell Growth and Treatment ResistanceLinna Zhang, Saurabh Agarwal, Jason M Shohet, et al.Pageof 4